BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

    NEXT STORY
    T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
    PREV STORY
    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

    NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ...

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

    LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Second Quarter 2019 Financial Results and Business Update Conference Call on August 28

    author_avatar
    NASDAQ Market News